Structure

Physi-Chem Properties

Molecular Weight:  664.22
Volume:  603.66
LogP:  -1.394
LogD:  -1.411
LogS:  -1.525
# Rotatable Bonds:  11
TPSA:  294.98
# H-Bond Aceptor:  18
# H-Bond Donor:  11
# Rings:  4
# Heavy Atoms:  18

MedChem Properties

QED Drug-Likeness Score:  0.063
Synthetic Accessibility Score:  5.212
Fsp3:  0.679
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.652
MDCK Permeability:  0.0001466914254706353
Pgp-inhibitor:  0.001
Pgp-substrate:  0.998
Human Intestinal Absorption (HIA):  0.995
20% Bioavailability (F20%):  0.974
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.214
Plasma Protein Binding (PPB):  60.75952911376953%
Volume Distribution (VD):  0.312
Pgp-substrate:  35.71146011352539%

ADMET: Metabolism

CYP1A2-inhibitor:  0.027
CYP1A2-substrate:  0.005
CYP2C19-inhibitor:  0.027
CYP2C19-substrate:  0.051
CYP2C9-inhibitor:  0.002
CYP2C9-substrate:  0.038
CYP2D6-inhibitor:  0.007
CYP2D6-substrate:  0.092
CYP3A4-inhibitor:  0.02
CYP3A4-substrate:  0.002

ADMET: Excretion

Clearance (CL):  0.793
Half-life (T1/2):  0.739

ADMET: Toxicity

hERG Blockers:  0.334
Human Hepatotoxicity (H-HT):  0.504
Drug-inuced Liver Injury (DILI):  0.396
AMES Toxicity:  0.391
Rat Oral Acute Toxicity:  0.176
Maximum Recommended Daily Dose:  0.002
Skin Sensitization:  0.954
Carcinogencity:  0.031
Eye Corrosion:  0.003
Eye Irritation:  0.014
Respiratory Toxicity:  0.05

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC476376

Natural Product ID:  NPC476376
Common Name*:   Kankanose
IUPAC Name:   [(2R,3R,4R,5R,6R)-5,6-dihydroxy-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-4-[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]methoxy]oxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
Synonyms:   Kankanose
Standard InCHIKey:  KNOFCZGZWCPZEU-QTPUSYSKSA-N
Standard InCHI:  InChI=1S/C28H40O18/c1-10-18(33)21(36)20(35)15(43-10)8-41-26-24(39)27(40)44-16(9-42-28-23(38)22(37)19(34)14(7-29)45-28)25(26)46-17(32)5-3-11-2-4-12(30)13(31)6-11/h2-6,10,14-16,18-31,33-40H,7-9H2,1H3/b5-3+/t10-,14+,15-,16+,18-,19+,20-,21+,22-,23+,24+,25+,26+,27+,28+/m0/s1
SMILES:  CC1C(C(C(C(O1)COC2C(C(OC(C2OC(=O)C=CC3=CC(=C(C=C3)O)O)COC4C(C(C(C(O4)CO)O)O)O)O)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL590293
PubChem CID:   46228757
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000476] Cinnamic acids and derivatives
        • [CHEMONTID:0001391] Hydroxycinnamic acids and derivatives
          • [CHEMONTID:0000059] Coumaric acids and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO6964 Cistanche tubulosa Species Orobanchaceae Eukaryota fresh stems n.a. n.a. PMID[20159656]
NPO6964 Cistanche tubulosa Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO6964 Cistanche tubulosa Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO6964 Cistanche tubulosa Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO6964 Cistanche tubulosa Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT993 Cell Line Hepatocyte Mus musculus Inhibition = -4.9 % PMID[522503]
NPT993 Cell Line Hepatocyte Mus musculus Inhibition = -1.3 % PMID[522503]
NPT993 Cell Line Hepatocyte Mus musculus Inhibition = -7.9 % PMID[522503]
NPT993 Cell Line Hepatocyte Mus musculus Inhibition = -2.8 % PMID[522503]
NPT1460 Cell Line L929 Mus musculus Inhibition = -1.1 % PMID[522503]
NPT1460 Cell Line L929 Mus musculus Inhibition = 2.2 % PMID[522503]
NPT1460 Cell Line L929 Mus musculus Inhibition = 1.3 % PMID[522503]
NPT1460 Cell Line L929 Mus musculus Inhibition = 0.8 % PMID[522503]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC476376 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.963 High Similarity NPC476380
0.963 High Similarity NPC269141
0.963 High Similarity NPC205864
0.963 High Similarity NPC76406
0.963 High Similarity NPC119537
0.963 High Similarity NPC175214
0.963 High Similarity NPC476384
0.963 High Similarity NPC476397
0.963 High Similarity NPC476381
0.963 High Similarity NPC247032
0.963 High Similarity NPC112
0.963 High Similarity NPC264632
0.963 High Similarity NPC96795
0.963 High Similarity NPC298257
0.963 High Similarity NPC476378
0.963 High Similarity NPC476375
0.9627 High Similarity NPC476377
0.9627 High Similarity NPC134405
0.9627 High Similarity NPC476385
0.9627 High Similarity NPC47471
0.9624 High Similarity NPC68092
0.9624 High Similarity NPC472350
0.9624 High Similarity NPC81515
0.9624 High Similarity NPC89105
0.9624 High Similarity NPC64141
0.9624 High Similarity NPC476383
0.9624 High Similarity NPC205195
0.9624 High Similarity NPC197316
0.9615 High Similarity NPC473285
0.9559 High Similarity NPC64195
0.9556 High Similarity NPC222433
0.9556 High Similarity NPC265648
0.9552 High Similarity NPC473799
0.9552 High Similarity NPC475530
0.9549 High Similarity NPC260425
0.947 High Similarity NPC471883
0.942 High Similarity NPC229505
0.9416 High Similarity NPC300894
0.9416 High Similarity NPC141455
0.9416 High Similarity NPC296954
0.9416 High Similarity NPC196063
0.9403 High Similarity NPC78363
0.9385 High Similarity NPC477293
0.9385 High Similarity NPC229784
0.9385 High Similarity NPC477294
0.9343 High Similarity NPC105005
0.9323 High Similarity NPC287597
0.9323 High Similarity NPC886
0.9323 High Similarity NPC34293
0.9308 High Similarity NPC232880
0.9254 High Similarity NPC476870
0.9248 High Similarity NPC254398
0.9242 High Similarity NPC219677
0.9231 High Similarity NPC476873
0.922 High Similarity NPC476398
0.922 High Similarity NPC94871
0.922 High Similarity NPC471062
0.922 High Similarity NPC306890
0.922 High Similarity NPC476386
0.922 High Similarity NPC473427
0.922 High Similarity NPC470933
0.922 High Similarity NPC259347
0.9214 High Similarity NPC232992
0.9209 High Similarity NPC34587
0.9209 High Similarity NPC100998
0.9209 High Similarity NPC476382
0.9209 High Similarity NPC252292
0.9209 High Similarity NPC34927
0.9191 High Similarity NPC171134
0.9191 High Similarity NPC321184
0.9191 High Similarity NPC328273
0.9191 High Similarity NPC321638
0.9173 High Similarity NPC473924
0.9155 High Similarity NPC257970
0.9155 High Similarity NPC470927
0.9143 High Similarity NPC476865
0.9137 High Similarity NPC476867
0.9111 High Similarity NPC263829
0.9098 High Similarity NPC138777
0.9098 High Similarity NPC225384
0.9098 High Similarity NPC46137
0.9098 High Similarity NPC235294
0.9098 High Similarity NPC246869
0.9084 High Similarity NPC106677
0.9071 High Similarity NPC476869
0.9071 High Similarity NPC476866
0.9071 High Similarity NPC476864
0.9071 High Similarity NPC476868
0.9065 High Similarity NPC40305
0.9044 High Similarity NPC157554
0.9021 High Similarity NPC188393
0.9021 High Similarity NPC470934
0.9014 High Similarity NPC23677
0.9008 High Similarity NPC471157
0.8993 High Similarity NPC140502
0.8993 High Similarity NPC296643
0.8986 High Similarity NPC202700
0.8939 High Similarity NPC471882
0.8939 High Similarity NPC173150
0.8939 High Similarity NPC156692
0.8939 High Similarity NPC35288
0.8939 High Similarity NPC471881
0.8939 High Similarity NPC45224
0.8936 High Similarity NPC262182
0.8936 High Similarity NPC287615
0.8936 High Similarity NPC216819
0.8936 High Similarity NPC83743
0.8931 High Similarity NPC126991
0.8931 High Similarity NPC83218
0.8929 High Similarity NPC478239
0.8921 High Similarity NPC186406
0.8913 High Similarity NPC100389
0.8913 High Similarity NPC220942
0.8913 High Similarity NPC226005
0.8905 High Similarity NPC470572
0.8897 High Similarity NPC106818
0.8889 High Similarity NPC254275
0.8889 High Similarity NPC69367
0.8881 High Similarity NPC80732
0.8881 High Similarity NPC201148
0.8881 High Similarity NPC3460
0.8881 High Similarity NPC192763
0.8881 High Similarity NPC215095
0.8881 High Similarity NPC261122
0.8881 High Similarity NPC28651
0.8881 High Similarity NPC199311
0.8881 High Similarity NPC210611
0.8881 High Similarity NPC300262
0.8865 High Similarity NPC110063
0.8864 High Similarity NPC61181
0.8857 High Similarity NPC157816
0.8846 High Similarity NPC52097
0.8836 High Similarity NPC87403
0.8806 High Similarity NPC184092
0.8797 High Similarity NPC103533
0.8797 High Similarity NPC288416
0.8769 High Similarity NPC11724
0.8768 High Similarity NPC186418
0.8768 High Similarity NPC37468
0.8759 High Similarity NPC35731
0.8759 High Similarity NPC476871
0.8741 High Similarity NPC199928
0.8732 High Similarity NPC297342
0.8732 High Similarity NPC292443
0.8732 High Similarity NPC232228
0.8731 High Similarity NPC225307
0.8722 High Similarity NPC252114
0.8707 High Similarity NPC471874
0.8705 High Similarity NPC101686
0.8705 High Similarity NPC469364
0.8705 High Similarity NPC65262
0.8699 High Similarity NPC85192
0.8699 High Similarity NPC125823
0.8699 High Similarity NPC143480
0.8699 High Similarity NPC7145
0.8692 High Similarity NPC476872
0.869 High Similarity NPC478242
0.869 High Similarity NPC90896
0.869 High Similarity NPC106138
0.869 High Similarity NPC283839
0.8686 High Similarity NPC28637
0.8676 High Similarity NPC478255
0.8657 High Similarity NPC264900
0.8657 High Similarity NPC108659
0.8657 High Similarity NPC79715
0.8657 High Similarity NPC231607
0.8639 High Similarity NPC289967
0.8639 High Similarity NPC478268
0.8639 High Similarity NPC472611
0.8639 High Similarity NPC472612
0.8626 High Similarity NPC266045
0.8626 High Similarity NPC55608
0.8621 High Similarity NPC473138
0.8621 High Similarity NPC28776
0.8582 High Similarity NPC94179
0.8571 High Similarity NPC478249
0.8571 High Similarity NPC269914
0.8571 High Similarity NPC304152
0.8561 High Similarity NPC123988
0.8552 High Similarity NPC18789
0.854 High Similarity NPC248307
0.854 High Similarity NPC65942
0.8531 High Similarity NPC113680
0.8531 High Similarity NPC204644
0.8531 High Similarity NPC278961
0.8529 High Similarity NPC253595
0.8529 High Similarity NPC307110
0.8507 High Similarity NPC90318
0.8503 High Similarity NPC12006
0.85 High Similarity NPC177035
0.85 High Similarity NPC471872
0.85 High Similarity NPC199459
0.85 High Similarity NPC154485
0.85 High Similarity NPC52277
0.8497 Intermediate Similarity NPC246024
0.8493 Intermediate Similarity NPC478237
0.8489 Intermediate Similarity NPC135127
0.8489 Intermediate Similarity NPC169398
0.8483 Intermediate Similarity NPC473867
0.8462 Intermediate Similarity NPC473873

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC476376 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9624 High Similarity NPD7266 Discontinued
0.8311 Intermediate Similarity NPD1653 Approved
0.8027 Intermediate Similarity NPD6190 Approved
0.7744 Intermediate Similarity NPD7685 Pre-registration
0.773 Intermediate Similarity NPD7074 Phase 3
0.773 Intermediate Similarity NPD7472 Approved
0.7669 Intermediate Similarity NPD7054 Approved
0.7636 Intermediate Similarity NPD7251 Discontinued
0.7607 Intermediate Similarity NPD7228 Approved
0.7576 Intermediate Similarity NPD6797 Phase 2
0.7534 Intermediate Similarity NPD230 Phase 1
0.75 Intermediate Similarity NPD3027 Phase 3
0.7485 Intermediate Similarity NPD7808 Phase 3
0.7429 Intermediate Similarity NPD1091 Approved
0.7381 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD8166 Discontinued
0.7358 Intermediate Similarity NPD8455 Phase 2
0.7347 Intermediate Similarity NPD1613 Approved
0.7347 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7338 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7324 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD6674 Discontinued
0.7289 Intermediate Similarity NPD3818 Discontinued
0.7284 Intermediate Similarity NPD6234 Discontinued
0.7251 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD7240 Approved
0.7214 Intermediate Similarity NPD1357 Approved
0.7188 Intermediate Similarity NPD37 Approved
0.7183 Intermediate Similarity NPD3705 Approved
0.716 Intermediate Similarity NPD4966 Approved
0.716 Intermediate Similarity NPD4965 Approved
0.716 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD4967 Phase 2
0.7135 Intermediate Similarity NPD8312 Approved
0.7135 Intermediate Similarity NPD8313 Approved
0.7075 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7066 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7066 Intermediate Similarity NPD6166 Phase 2
0.7066 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7021 Intermediate Similarity NPD9545 Approved
0.7018 Intermediate Similarity NPD6559 Discontinued
0.7007 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7007 Intermediate Similarity NPD969 Suspended
0.7007 Intermediate Similarity NPD228 Approved
0.6985 Remote Similarity NPD3022 Approved
0.6985 Remote Similarity NPD3021 Approved
0.6981 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6975 Remote Similarity NPD1934 Approved
0.6974 Remote Similarity NPD7097 Phase 1
0.6974 Remote Similarity NPD4978 Clinical (unspecified phase)
0.6968 Remote Similarity NPD1652 Phase 2
0.6963 Remote Similarity NPD1358 Approved
0.6933 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6932 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6923 Remote Similarity NPD4628 Phase 3
0.6897 Remote Similarity NPD9269 Phase 2
0.6894 Remote Similarity NPD3455 Phase 2
0.6886 Remote Similarity NPD7199 Phase 2
0.6886 Remote Similarity NPD8127 Discontinued
0.6854 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6852 Remote Similarity NPD4380 Phase 2
0.6842 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6842 Remote Similarity NPD5844 Phase 1
0.6842 Remote Similarity NPD5124 Phase 1
0.6839 Remote Similarity NPD2029 Clinical (unspecified phase)
0.6831 Remote Similarity NPD5536 Phase 2
0.6829 Remote Similarity NPD1465 Phase 2
0.6813 Remote Similarity NPD7237 Clinical (unspecified phase)
0.6807 Remote Similarity NPD7075 Discontinued
0.6806 Remote Similarity NPD5125 Phase 3
0.6806 Remote Similarity NPD5126 Approved
0.6797 Remote Similarity NPD6653 Approved
0.6788 Remote Similarity NPD3817 Phase 2
0.6779 Remote Similarity NPD9494 Approved
0.6776 Remote Similarity NPD4060 Phase 1
0.6765 Remote Similarity NPD3134 Approved
0.6759 Remote Similarity NPD3496 Discontinued
0.6757 Remote Similarity NPD7680 Approved
0.6732 Remote Similarity NPD4340 Discontinued
0.673 Remote Similarity NPD5058 Phase 3
0.6728 Remote Similarity NPD3687 Approved
0.6728 Remote Similarity NPD3686 Approved
0.6727 Remote Similarity NPD2977 Approved
0.6727 Remote Similarity NPD2978 Approved
0.6727 Remote Similarity NPD2801 Approved
0.6714 Remote Similarity NPD7843 Approved
0.6712 Remote Similarity NPD422 Phase 1
0.6711 Remote Similarity NPD6233 Phase 2
0.6706 Remote Similarity NPD7184 Clinical (unspecified phase)
0.669 Remote Similarity NPD9381 Approved
0.669 Remote Similarity NPD7157 Approved
0.669 Remote Similarity NPD9384 Approved
0.6689 Remote Similarity NPD7095 Approved
0.6687 Remote Similarity NPD5402 Approved
0.6685 Remote Similarity NPD6843 Phase 3
0.6685 Remote Similarity NPD6842 Approved
0.6685 Remote Similarity NPD6841 Approved
0.6667 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5736 Approved
0.6667 Remote Similarity NPD826 Approved
0.6667 Remote Similarity NPD3620 Phase 2
0.6667 Remote Similarity NPD825 Approved
0.6667 Remote Similarity NPD2861 Phase 2
0.6667 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6667 Remote Similarity NPD9570 Approved
0.6647 Remote Similarity NPD3882 Suspended
0.6646 Remote Similarity NPD4160 Clinical (unspecified phase)
0.6646 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6645 Remote Similarity NPD3764 Approved
0.6644 Remote Similarity NPD3094 Phase 2
0.6631 Remote Similarity NPD8319 Approved
0.6631 Remote Similarity NPD8320 Phase 1
0.6627 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6624 Remote Similarity NPD5763 Approved
0.6624 Remote Similarity NPD5762 Approved
0.6623 Remote Similarity NPD1933 Approved
0.6623 Remote Similarity NPD4908 Phase 1
0.6623 Remote Similarity NPD447 Suspended
0.6622 Remote Similarity NPD2982 Phase 2
0.6622 Remote Similarity NPD2983 Phase 2
0.6622 Remote Similarity NPD9622 Approved
0.6621 Remote Similarity NPD9268 Approved
0.6605 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6604 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6604 Remote Similarity NPD1878 Clinical (unspecified phase)
0.659 Remote Similarity NPD3751 Discontinued
0.6587 Remote Similarity NPD5353 Approved
0.6585 Remote Similarity NPD7458 Discontinued
0.6584 Remote Similarity NPD1511 Approved
0.6581 Remote Similarity NPD5314 Approved
0.6579 Remote Similarity NPD8151 Discontinued
0.6575 Remote Similarity NPD4626 Approved
0.6571 Remote Similarity NPD9280 Clinical (unspecified phase)
0.6566 Remote Similarity NPD7945 Clinical (unspecified phase)
0.6564 Remote Similarity NPD5403 Approved
0.6561 Remote Similarity NPD2935 Discontinued
0.6558 Remote Similarity NPD3061 Approved
0.6558 Remote Similarity NPD3059 Approved
0.6558 Remote Similarity NPD3062 Approved
0.6556 Remote Similarity NPD3018 Phase 2
0.6554 Remote Similarity NPD2981 Phase 2
0.655 Remote Similarity NPD6232 Discontinued
0.6549 Remote Similarity NPD5283 Phase 1
0.6547 Remote Similarity NPD2684 Approved
0.6541 Remote Similarity NPD5698 Clinical (unspecified phase)
0.6538 Remote Similarity NPD4536 Approved
0.6538 Remote Similarity NPD4537 Clinical (unspecified phase)
0.6538 Remote Similarity NPD4538 Approved
0.6536 Remote Similarity NPD6798 Discontinued
0.6536 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6536 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6536 Remote Similarity NPD8150 Discontinued
0.6532 Remote Similarity NPD7473 Discontinued
0.6527 Remote Similarity NPD7819 Suspended
0.6517 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6516 Remote Similarity NPD6355 Discontinued
0.6516 Remote Similarity NPD555 Phase 2
0.6507 Remote Similarity NPD5691 Approved
0.6506 Remote Similarity NPD6386 Approved
0.6506 Remote Similarity NPD6385 Approved
0.6503 Remote Similarity NPD1512 Approved
0.65 Remote Similarity NPD4109 Clinical (unspecified phase)
0.65 Remote Similarity NPD4110 Phase 3
0.6497 Remote Similarity NPD7549 Discontinued
0.6494 Remote Similarity NPD6663 Approved
0.649 Remote Similarity NPD9620 Approved
0.649 Remote Similarity NPD9621 Approved
0.649 Remote Similarity NPD9619 Approved
0.6489 Remote Similarity NPD7435 Discontinued
0.6486 Remote Similarity NPD7699 Phase 2
0.6486 Remote Similarity NPD3092 Approved
0.6486 Remote Similarity NPD7700 Phase 2
0.6481 Remote Similarity NPD4357 Discontinued
0.6478 Remote Similarity NPD2424 Discontinued
0.6475 Remote Similarity NPD290 Approved
0.6474 Remote Similarity NPD2492 Phase 1
0.6467 Remote Similarity NPD6801 Discontinued
0.6467 Remote Similarity NPD8651 Approved
0.6467 Remote Similarity NPD3225 Approved
0.6463 Remote Similarity NPD1778 Approved
0.6463 Remote Similarity NPD2122 Discontinued
0.6458 Remote Similarity NPD6671 Approved
0.6457 Remote Similarity NPD8470 Clinical (unspecified phase)
0.6453 Remote Similarity NPD3787 Discontinued
0.6452 Remote Similarity NPD4140 Approved
0.6452 Remote Similarity NPD1558 Phase 1
0.6452 Remote Similarity NPD943 Approved
0.6446 Remote Similarity NPD7028 Phase 2
0.6442 Remote Similarity NPD5401 Approved
0.6442 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6442 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6441 Remote Similarity NPD7038 Approved
0.6441 Remote Similarity NPD7039 Approved
0.6438 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6438 Remote Similarity NPD4236 Phase 3
0.6438 Remote Similarity NPD3060 Approved
0.6438 Remote Similarity NPD4237 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data